Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.46 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.46 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.46 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.46 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | TACR2 | P21452 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | OGA | O60502 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16367579 | 0.89 | SSTR1 (0.49) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL17301567 | 0.88 | SSTR1 (0.48) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL17679385 | 0.88 | SSTR1 (0.50) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL28577540 | 0.87 | SSTR1 (0.58) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL31421192 | 0.87 | SSTR1 (0.58) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL24045910 | 0.87 | SSTR1 (0.58) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL11997440 | 0.87 | LGALS8 (0.44) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL11921892 | 0.87 | LGALS8 (0.44) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL10148590 | 0.87 | LGALS8 (0.57) | LGALS8SLC6A2SSTR1SSTR2SSTR4 | |
| SCHEMBL1772243 | 0.86 | SSTR1 (0.60) | LGALS8SLC6A2SSTR1SSTR2SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158155-A1 | Cell Surface Receptor Binding Compounds and Conjugates | LYCIA THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158155-A1 | Cell Surface Receptor Binding Compounds and Conjugates | M6PR, ASGR1, IGF2R | LGALS8 109/4885SLC6A2 1205/4885SSTR1 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.